About
Elda Grabocka, PhD, is an Associate Professor in the Department of Pharmacology, Physiology & Cancer Biology at the College of Life Sciences. Her research focuses on RAS-driven cancers, particularly pancreatic cancer, where she investigates stress adaptation mechanisms, drug resistance, and therapeutic targeting strategies.
Education includes:
- PhD, Structural Biology and Molecular Pharmacology (2007)
- BS, Biology, Washington College
Dr. Grabocka's research explores how mutant RAS genes (KRAS, NRAS, HRAS) drive tumor progression in 30% of human cancers. Key areas include:
- Stress granule formation in KRAS-driven drug resistance
- 3D cell culture and mouse modeling of pancreatic cancer
- Oncogenic signaling and stress response interplay
- Reprogramming of DNA damage pathways in cancer
Her work aims to identify novel therapeutic targets for aggressive cancers lacking treatment options.
0Publications listed
Find Elda Grabocka elsewhere
Related Searches
You Might Also Like
Tikvah Katheryn HayesUniversity of California, Los Angeles · Assistant Professor
Neal RosenCornell University · Professor
Jeffrey KlompMichigan State University · Assistant Professor
Shohei KoideNew York University · Professor
Channing J. DerUniversity of North Carolina at Chapel Hill · Professor
Channing DerUniversity of North Carolina at Chapel Hill · Professor